Recital 11, Regulation (EU) 2022/2330

In force

The Commission also considers that, as the exposure assessment for human health and for the environment was conducted based on a maximum size of the biocidal product, the terms and conditions of the authorisation should include that no biocidal product of a greater size should be made available on the market.